Literature DB >> 26216936

Phospholipid scramblase 1 is required for β2-glycoprotein I binding in hypoxia and reoxygenation-induced endothelial inflammation.

Emily Archer Slone1, Michael R Pope1, Sherry D Fleming2.   

Abstract

Multiple pathologic conditions, including hemorrhage, tumor angiogenesis, and ischemia-reperfusion events, will result in hypoxia and subsequent reperfusion. Previous studies have analyzed the lipid changes within whole tissues and indicated that ischemia-reperfusion altered tissue and cellular phospholipids. Using an in vitro cell culture model of hypoxia and reoxygenation, we examined the endothelial lipid changes. We hypothesized that phospholipid scramblase 1, a protein that regulates bilayer asymmetry, is involved in altering the phospholipids of endothelial cells during hypoxia, a component of ischemia, leading to β2-glycoprotein I and IgM binding and subsequent lipid-mediated, inflammatory responses. We have completed the first comprehensive study of steady-state phospholipid scramblase 1 mRNA levels, protein expression, and activity under conditions of hypoxia and reoxygenation. Phospholipid scramblase 1 regulates phosphatidylserine exposure in response to oxygen stress, leading to β2-glycoprotein I and IgM binding and lipid-mediated, inflammatory responses. © Society for Leukocyte Biology.

Entities:  

Keywords:  Ischemia and reperfusion; apolipoprotein H; eicosanoids

Mesh:

Substances:

Year:  2015        PMID: 26216936      PMCID: PMC4600063          DOI: 10.1189/jlb.3A1014-480R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  63 in total

1.  Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor.

Authors:  Melanie L Hart; Almut Grenz; Iris C Gorzolla; Jens Schittenhelm; Julee H Dalton; Holger K Eltzschig
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

2.  β₂-glycoprotein I: a novel component of innate immunity.

Authors:  Cetin Agar; Philip G de Groot; Matthias Mörgelin; Stephanie D D C Monk; Gwendolyn van Os; Johannes H M Levels; Bas de Laat; Rolf T Urbanus; Heiko Herwald; Tom van der Poll; Joost C M Meijers
Journal:  Blood       Date:  2011-03-31       Impact factor: 22.113

3.  Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells.

Authors:  J F Schmedtje; Y S Ji; W L Liu; R N DuBois; M S Runge
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

4.  Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome.

Authors:  Olga Amengual; Tatsuya Atsumi; Kenji Oku; Eriko Suzuki; Tetsuya Horita; Shinsuke Yasuda; Takao Koike
Journal:  Mod Rheumatol       Date:  2012-04-24       Impact factor: 3.023

5.  Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation.

Authors:  Sherry D Fleming; Michael R Pope; Sara M Hoffman; Tiffany Moses; Urska Bukovnik; John M Tomich; Lynn M Wagner; Keith M Woods
Journal:  J Immunol       Date:  2010-10-18       Impact factor: 5.422

6.  Isolation of an erythrocyte membrane protein that mediates Ca2+-dependent transbilayer movement of phospholipid.

Authors:  F Bassé; J G Stout; P J Sims; T Wiedmer
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

7.  Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia.

Authors:  Eduardo Candelario-Jalil; Armando González-Falcón; Michel García-Cabrera; Dalia Alvarez; Said Al-Dalain; Gregorio Martínez; Olga Sonia León; Joe E Springer
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

Review 8.  Hypoxia sensing and pathways of cytosolic Ca2+ increases.

Authors:  Emil C Toescu
Journal:  Cell Calcium       Date:  2004 Sep-Oct       Impact factor: 6.817

9.  Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia.

Authors:  A P Levy; N S Levy; S Wegner; M A Goldberg
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

10.  Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells.

Authors:  A Namiki; E Brogi; M Kearney; E A Kim; T Wu; T Couffinhal; L Varticovski; J M Isner
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

View more
  5 in total

1.  Attenuation of endothelial phosphatidylserine exposure decreases ischemia-reperfusion induced changes in microvascular permeability.

Authors:  Aaron Strumwasser; Aditi Bhargava; Gregory P Victorino
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

2.  Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia.

Authors:  Rupert L Mayer; Josef D Schwarzmeier; Marlene C Gerner; Andrea Bileck; Johanna C Mader; Samuel M Meier-Menches; Samuel M Gerner; Klaus G Schmetterer; Tobias Pukrop; Albrecht Reichle; Astrid Slany; Christopher Gerner
Journal:  Mol Cell Proteomics       Date:  2017-12-01       Impact factor: 5.911

3.  Extracellular vesicles released by J774A.1 macrophages reduce the bacterial load in macrophages and in an experimental mouse model of tuberculosis.

Authors:  Mariano García-Martínez; Luis Vázquez-Flores; Violeta D Álvarez-Jiménez; Jessica Castañeda-Casimiro; Miguel Ibáñez-Hernández; Luvia Enid Sánchez-Torres; Jorge Barrios-Payán; Dulce Mata-Espinosa; Sergio Estrada-Parra; Rommel Chacón-Salinas; Jeanet Serafín-López; Isabel Wong-Baeza; Rogelio Hernández-Pando; Iris Estrada-García
Journal:  Int J Nanomedicine       Date:  2019-08-20

Review 4.  Phospholipid Scramblases: Role in Cancer Progression and Anticancer Therapeutics.

Authors:  Himadri Gourav Behuria; Sabyasachi Dash; Santosh Kumar Sahu
Journal:  Front Genet       Date:  2022-03-29       Impact factor: 4.599

5.  Beta2 glycoprotein I-derived therapeutic peptides induce sFlt-1 secretion to reduce melanoma vascularity and growth.

Authors:  Haley Smalley; Jennifer M Rowe; Fernando Nieto; Jazmin Zeledon; Kellyn Pollard; John M Tomich; Sherry D Fleming
Journal:  Cancer Lett       Date:  2020-09-04       Impact factor: 8.679

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.